Open access · US-GOV via ClinicalTrials.gov Clinical trial

Medication (de)Prescribing in Hospitalized Geriatric Patients With Sarcopenia, Less is More

Authors not listed

Zuyderland Medisch Centrum · 2023

Dysbiosis Human Randomized controlled trial Review

Abstract

The goal of this clinical trial is to compare the effects of a deprescribing pharmacotherapy approach to the STOPP-START approach (usual care) in geriatric patients with sarcopenia and polypharmacy. The main question it aims to answer is the number and type of medication that can be stopped in this population without being restarted within 6 months. After inclusion a medication review is performed by a team consisting of the researcher, a geriatrician and a hospital pharmacist, according to the protocol within which the patient was randomised. Participants are follow up at appointments after 1, 3 and 6 months. At these appointments, questionnaires are administered about the quality of life and complications related to medication.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source: ClinicalTrials.gov
Canonical: link ↗
Fetched: 2026-10-18 MST

Cite this

APA

Anonymous. (2023). Medication (de)Prescribing in Hospitalized Geriatric Patients With Sarcopenia, Less is More. <em>Zuyderland Medisch Centrum</em>. https://clinicaltrials.gov/study/NCT05757765

Vancouver

Anonymous. Medication (de)Prescribing in Hospitalized Geriatric Patients With Sarcopenia, Less is More. Zuyderland Medisch Centrum. 2023.

BibTeX

@misc{anon2023Medica, title = {Medication (de)Prescribing in Hospitalized Geriatric Patients With Sarcopenia, Less is More}, author = {Anonymous}, journal = {Zuyderland Medisch Centrum}, year = {2023}, }